
Park Medi World IPO Listing at 4% Premium at ₹155.60 Per Share
Posted by : sachet | Wed Dec 17 2025

Park Medi World IPO listing: The Park Medi World IPO was subscribed 8.52 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 12.07 times, and non-institutional investors (NIIs) received 15.93 times. The retail quota of the issue was subscribed to 35.00%. Before delving deeper into the topic, go through the details of the Park Medi World IPO.
Park Medi World IPO
It is a book-building issue of ₹920.00 crore of shares. The issue is entirely a fresh issue of 4.75 crore shares. The IPO is expected to be listed on the BSE and NSE with a tentative listing date of 17th December 2025. The Vidya Wires IPO is expected to take place from 10th December 2025 to 12th December 2025. The face value of Vidya Wires IPO shares is ₹2 per share, and the IPO price is set at ₹162 per share.
| IPO Allotment Date | 15th December 2025 |
| IPO Open Date | 10th December 2025 |
| IPO Close Date | 12th December 2025 |
| Refund Initiation | 16th December 2025 |
| Issue Size | 5,67,90,123 shares(aggregating up to ₹920.00 Cr) |
| Fresh Issue | 4,75,30,864 shares(aggregating up to ₹770.00 Cr) |
| Offer for Sale | 92,59,259 shares of ₹2(aggregating up to ₹150.00 Cr) |
| Face Value | ₹2per share |
| Lot Size | 92 Shares |
| Issue Price | ₹154 to ₹162 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE NSE |
| Listing Date | 17th December 2025 |
Park Medi World IPO Listing
On the BSE platforms, Park Medi World shares are listed at ₹155.60 per share, reflecting a 4% premium over the issue price of ₹162 per share. On the other hand, on the NSE platform, shares are listed at ₹158.80 per share, reflecting a premium of 2% from their issue price of ₹162 per share.
About the Park Medi World IPO
Park Medi World was established in 2011. Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025. The company operates 14 multi-speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also certified by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan. Park Hospital offers more than 30 super speciality and speciality services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
Park Medi World Limited Financials
The company’s financial analysis is essential before applying for Park Medi World Limited’s IPO. Refer to the table to learn about Vidya Wires Limited’s financial information.
| Year Ended | 30th Sep 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 2,320.93 | 2,133.70 | 1,912.10 | 1,592.82 |
| Revenue | 839.39 | 1,425.97 | 1,263.08 | 1,272.18 |
| Profit After Tax | 139.14 | 213.22 | 152.01 | 228.19 |
| EBITDA | 217.14 | 372.17 | 310.30 | 390.34 |
| Net Worth | 1,153.05 | 1,021.86 | 858.63 | 667.55 |
| Reserves and Surplus | 1,187.77 | 1,049.40 | 858.63 | 653.09 |
| Total Borrowings | 733.91 | 682.07 | 686.71 | 575.68 |
Explanation
Park Medi World Limited’s revenue increased by 13% from ₹1,263.08 crores in March 2024 to ₹1,425.97 crores in March 2025. Moreover, the company’s PAT increased by 40% from ₹152.01 crores in March 2024 to ₹213.22 crores in March 2025.
Recent Articles
Best Penny Stocks for Long Term in India | Penny Stocks in 2025
Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY
Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY
Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

